Skip to main content
Terug
Watch Compare

Concord Medical Services Holdings Ltd

Datakwaliteit: 100%
CCM
NYSE Services Health Services
€ 3,67
€ 0,00 (0,00%)
Marktkapitalisatie: 15,93 M
Prijs
€ 3,67
Marktkapitalisatie
15,93 M
Dagbereik
€ 3,67 — € 3,67
52-Weeksbereik
€ 3,18 — € 10,77
Volume
6
Openen € 3,67
50D / 200D Gem.
€ 3,82
3,84% below
50D / 200D Gem.
€ 4,80
23,62% below

Quick Summary

Belangrijkste Punten

Revenue grew 11,38% annually over 5 years — strong growth
Negative free cash flow of -75,15 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 41,88%
Capital intensive — 39,27% of revenue goes to capex

Groei

Revenue Growth (5Y)
11,38%
Boven sectorgemiddelde (4,21%)
Revenue (1Y)-30,50%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROIC-8,58%
Net Margin-80,28%
Op. Margin-138,60%

Veiligheid

Debt / Equity
N/A
Current Ratio0,46
Interest Coverage-2,75

Waardering

PE (TTM)
-0,38
Boven sectorgemiddelde (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Services sector mediaan (502 peers)
Metriek Aandeel Sector Mediaan
P/E -0,4 -1,2
P/B — 1,4
ROE % — -15,7
Net Margin % -80,3 -18,3
Rev Growth 5Y % 11,4 4,2
D/E — 0,4

All Fundamental Metrics
Growth
Revenue Growth (1Y) -30,50% Revenue Growth (3Y) -12,33%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 11,38% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 52,60 M Net Income (TTM) -42,23 M
ROE N/A ROA -4,76%
Gross Margin -20,62% Operating Margin -138,60%
Net Margin -80,28% Free Cash Flow (TTM) -75,15 M
ROIC -8,58% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,46
Interest Coverage -2,75 Asset Turnover 0,06
Working Capital -156,37 M Tangible Book Value -430,83 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -0,38 Forward P/E N/A
P/B Ratio N/A P/S Ratio 0,30
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -471,61%
Market Cap 15,93 M Enterprise Value 444,35 M
Per Share
EPS (Diluted TTM) -0,32 Revenue / Share 12,12
FCF / Share -17,31 OCF / Share -12,55
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 39,27% FCF Conversion 177,96%
SBC-Adj. FCF N/A Growth Momentum -41,88

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 52,60 M 75,69 M 68,45 M 76,21 M 34,18 M
Net Income -42,23 M -41,93 M -70,99 M -42,59 M -47,51 M
EPS (Diluted) -0,32 -0,32 -0,54 — —
Gross Profit -10,85 M -10,79 M -22,10 M -8,93 M 2,01 M
Operating Income -72,91 M -65,21 M -76,13 M -71,92 M -48,43 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 26,47 M 23,33 M 17,45 M 11,58 M 12,47 M
Income Tax -2,40 M -3,46 M -10,28 M -1,03 M -5,77 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 921,51 M 852,68 M 870,63 M 977,62 M 817,55 M
Total Liabilities 699,88 M 606,62 M 578,39 M 547,07 M 449,61 M
Shareholders' Equity -312,41 M -298,87 M -270,25 M -215,00 M -101,60 M
Total Debt 458,04 M 325,87 M 382,77 M 363,29 M 305,37 M
Cash & Equivalents 29,62 M 8,19 M 22,95 M 24,70 M 51,23 M
Current Assets 134,80 M 86,93 M 110,16 M 91,72 M 103,60 M
Current Liabilities 291,17 M 274,85 M 162,57 M 126,25 M 78,49 M